Overview – Synergene Active Ingredients SynergeneAPI

Company Overview

Synergene Active Ingredients Private Limited

Synergene Active Ingredients manufactures active pharmaceutical ingredients (APIs), intermediates and speciality chemicals, and partners with pharmaceutical companies as a contract development and manufacturing organisation (CDMO). Founded in 2006 by Mr. Surya Prakash Rao Nalla, Synergene has 700+ people and 1000 KL of reactor capacity across 6 locations in India, and exports to 65+ countries.

We have been inspected by the USFDA, PMDA and ANVISA, and we hold 9 CEPs, 6 USDMFs and 9 CBPFs, with DMFs filed in 65+ countries. Backward integration from intermediates to APIs keeps quality and supply consistent, and our CDMO team supports partners from development to scale-up.

Vision, mission and values

Vision: “To be a global, integrated company that manufactures and supplies high-quality products through science-based technology and innovation, and to expand our product portfolio to become a major player in anti-fungal and anti-depressant APIs.”
Mission: “To provide health and welfare through high-quality, reliable products at reasonably affordable prices.”
Values: “Creating value: we create and sustain value for our customers and community.”
“Integrity and excellence: we build a culture of commitment, integrity and the continuous pursuit of excellence.”
“Employer of choice: we aim to be sought after as an employer and respected by our partners and competitors.
Transparency and respect: we conduct business with transparency and respect for people.

Our longest-established products include Terbinafine Hydrochloride, Fluconazole, Voriconazole, Losartan Potassium and Escitalopram Oxalate. We hold process patents for Escitalopram Oxalate, Dapoxetine Hydrochloride, Luliconazole and Terbinafine Hydrochloride.

Our story

Synergene began in 2006 with Synergene Unit I in Hyderabad, our R&D centre with pilot-scale manufacturing. In 2010 we opened our first site in Visakhapatnam, Synergene Unit II. Unit IV joined in 2018 and Unit III followed in 2019, then Susrutha Bio Sciences, our intermediates subsidiary, in 2022, and Synac Pharmaceuticals, our wholly owned subsidiary, in 2023. Today we operate six manufacturing sites: Unit I in Hyderabad and five sites in Visakhapatnam.

Quality

Consistent quality, batch after batch, under GMP.

Expertise

Chemistry know-how built over two decades, led by a founder with 40+ years of experience.

Transparency

Open, timely communication with customers and regulators.

Investment

Continued investment in capacity, including room for a further 700 KL at Synac.

Global reach

Customers in 65+ countries.

About Us

Business Segments

Address

Synergene Active Ingredients Corporate Office, H.No.8-2-293/82/J-III/304-O, Plot No.304, Road No.78, Jubilee Hills, Hyderabad 500033, Telangana, India.

+91-40-23817500

sales@synergeneapi.com